132 related articles for article (PubMed ID: 37349667)
1. Degradants of Tenofovir Disoproxil Fumarate Under Forced Yet Mild Thermal Stress: Isolation, Comprehensive Structural Elucidation, and Mechanism.
Ranga M; Modini AK; Nallajarla AK; Doddipalla R; Kaliyaperumal M; Goswami A
AAPS PharmSciTech; 2023 Jun; 24(6):139. PubMed ID: 37349667
[TBL] [Abstract][Full Text] [Related]
2. Isolation, LC-MS/MS and 2D-NMR characterization of alkaline degradants of tenofovir disoproxil fumarate.
Anandgaonkar V; Gupta A; Kona S; Talluri MV
J Pharm Biomed Anal; 2015 Mar; 107():175-85. PubMed ID: 25594895
[TBL] [Abstract][Full Text] [Related]
3. Stability behaviour of antiretroviral drugs and their combinations. 2: Characterization of interaction products of lamivudine and tenofovir disoproxil fumarate by mass and NMR spectrometry.
Kurmi M; Kushwah BS; Sahu A; Narayanam M; Singh S
J Pharm Biomed Anal; 2016 Jun; 125():245-59. PubMed ID: 27042808
[TBL] [Abstract][Full Text] [Related]
4. Stability behaviour of antiretroviral drugs and their combinations. 4: Characterization of degradation products of tenofovir alafenamide fumarate and comparison of its degradation and stability behaviour with tenofovir disoproxil fumarate.
Golla VM; Kurmi M; Shaik K; Singh S
J Pharm Biomed Anal; 2016 Nov; 131():146-155. PubMed ID: 27589032
[TBL] [Abstract][Full Text] [Related]
5. Identification, Isolation, and Structural Characterization of Novel Forced Degradation Products of Darunavir Using Advanced Analytical Techniques Like UPLC-MS, Prep-HPLC, HRMS, NMR, and FT-IR Spectroscopy.
Modini AK; Ranga M; Puppala U; Kaliyapermal M; Geereddy MKR; Samineni R; Grover P; Konidala SK
Chromatographia; 2023; 86(1):63-78. PubMed ID: 36531783
[TBL] [Abstract][Full Text] [Related]
6. Forced degradation and impurity profiling: recent trends in analytical perspectives.
Jain D; Basniwal PK
J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
[TBL] [Abstract][Full Text] [Related]
7. Identification, isolation and characterization of dolutegravir forced degradation products and their cytotoxicity potential.
Saida SJ; Manikandan A; Kaliyaperumal M; Rumalla CS; Khan AA; Jayaraman VB; Yanaka R; Venkat Rao S
J Pharm Biomed Anal; 2019 Sep; 174():588-594. PubMed ID: 31261040
[TBL] [Abstract][Full Text] [Related]
8. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
[TBL] [Abstract][Full Text] [Related]
9. Degradation study of irbesartan: Isolation and structural elucidation of novel degradants.
Mutha VVSRNAK; Guduru S; Kaliyaperumal M; Rumalla CS; Maddi SR; Korupolu RB; Gajbhiye SB
J Pharm Biomed Anal; 2018 Aug; 157():180-188. PubMed ID: 29803909
[TBL] [Abstract][Full Text] [Related]
10. Stability behaviour of antiretroviral drugs and their combinations. 3: Characterization of interaction products of emtricitabine and tenofovir disoproxil fumarate by mass spectrometry.
Kurmi M; Singh DK; Tiwari S; Sharma P; Singh S
J Pharm Biomed Anal; 2016 Sep; 128():438-446. PubMed ID: 27344633
[TBL] [Abstract][Full Text] [Related]
11. Stability behaviour of antiretroviral drugs and their combinations. 10: LC-HRMS, LC-MS
Singh DK; Sahu A; Wani AA; Bharatam PV; Kotimoole CN; Batkulwar KB; Deshpande AY; Giri S; Singh S
Eur J Pharm Biopharm; 2019 Sep; 142():165-178. PubMed ID: 31226366
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel human circulating metabolite of tenofovir disoproxil fumarate with LC-MS/MS.
Nye LC; Gray N; McClure M; Boffit M; Holmes E; Plumb RS; Wilson ID
Bioanalysis; 2015; 7(6):643-52. PubMed ID: 25871584
[TBL] [Abstract][Full Text] [Related]
13. Engineering of a hybrid polymer-lipid nanocarrier for the nasal delivery of tenofovir disoproxil fumarate: physicochemical, molecular, microstructural, and stability evaluation.
Pokharkar VB; Jolly MR; Kumbhar DD
Eur J Pharm Sci; 2015 Apr; 71():99-111. PubMed ID: 25708940
[TBL] [Abstract][Full Text] [Related]
14. Structural identification of degradants of moexipril by LC-MS/MS.
Challa PR; K R; K M V NR
Biomed Chromatogr; 2017 Nov; 31(11):. PubMed ID: 28493358
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of pseudo degradation products of acalabrutinib using ESI-HRMS/MS and NMR: Formation of possible geometrical isomers.
Panda S; Das M; Kandula RR; Gajjela R; Ravuri NDH; Kumar H; Kalamse S; Mathur A; Roy A; Bagadi M
J Pharm Biomed Anal; 2023 Feb; 225():115214. PubMed ID: 36621281
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of forced degradation products of sertraline hydrochloride using UPLC, ultra-high-performance liquid Chromatography-Quadrupole-Time of flight mass spectrometry (UHPLC-Q-TOF/MS/MS) and NMR.
Grover P; Bhardwaj M; Mukherjee D
J Pharm Biomed Anal; 2022 Nov; 221():115045. PubMed ID: 36126615
[TBL] [Abstract][Full Text] [Related]
17. Stability behaviour of antiretroviral drugs and their combinations. 8: Characterization and in-silico toxicity prediction of degradation products of efavirenz.
Kurmi M; Sahu A; Singh DK; Singh IP; Singh S
J Pharm Biomed Anal; 2018 Jan; 148():170-181. PubMed ID: 29055875
[TBL] [Abstract][Full Text] [Related]
18. Effect of Pregnancy and Concomitant Antiretrovirals on the Pharmacokinetics of Tenofovir in Women With HIV Receiving Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Versus Women With HBV Receiving Tenofovir Disoproxil Fumarate Monotherapy.
Bukkems VE; Smolders EJ; Jourdain G; Burger DM; Colbers AP; Cressey TR;
J Clin Pharmacol; 2021 Mar; 61(3):388-393. PubMed ID: 32960984
[TBL] [Abstract][Full Text] [Related]
19. Stability behaviour of antiretroviral drugs and their combinations. 9: Identification of incompatible excipients.
Kurmi M; Sahu A; Ladumor MK; Kumar Bansal A; Singh S
J Pharm Biomed Anal; 2019 Mar; 166():174-182. PubMed ID: 30654205
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of major degradation products of Eprinomectin drug substance including degradation pathways using LC-HRMS and NMR.
Adhikari S; Rustum AM
J Pharm Biomed Anal; 2022 Jun; 215():114767. PubMed ID: 35447491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
